Skip to main content
PMC home page
Clinical and Diagnostic Laboratory Immunology logoLink to Clinical and Diagnostic Laboratory Immunology
. 1995 Sep;2(5):542–548. doi: 10.1128/cdli.2.5.542-548.1995

Monoclonal rat antibodies directed against Toxoplasma gondii suitable for studying tachyzoite-bradyzoite interconversion in vivo.

U Gross 1, H Bormuth 1, C Gaissmaier 1, C Dittrich 1, V Krenn 1, W Bohne 1, D J Ferguson 1
PMCID: PMC170197  PMID: 8548532

Abstract

We previously reported the in vitro analysis of stage differentiation of Toxoplasma gondii in murine bone marrow-derived macrophages. The purpose of this study was to generate monoclonal rat antibodies that might be suitable for investigating tachyzoite-bradyzoite interconversion in vivo with the murine model. Immunization of Fischer rats with cysts of T. gondii NTE resulted in the generation of seven monoclonal antibodies of the immunoglobulin G2a, G2b, or M isotype, which were further characterized by the immunoblot technique, immunofluorescence assay, immunohistology, and immunoelectron microscopy. Immunoblots demonstrated specific reactivity of five monoclonal antibodies with proteins with molecular masses of 40, 52, 55, 60, 64, 65, and 115 kDa. One antibody (CC2) appeared to recognize a differently expressed antigen depending on the parasite stage, reacting with a 40-kDa molecule in tachyzoites and a 115-kDa antigen in bradyzoites and oocysts. Several other monoclonal antibodies were shown to be stage specific and to react in immunofluorescence assays or in immunoblots with either tachyzoites or bradyzoites. Kinetics of stage conversion in vitro could be monitored by immunofluorescence with two of these monoclonal antibodies. Preliminary immunohistological investigations of tissue sections from infected mice demonstrated the possible usefulness of these monoclonal antibodies for future in vivo studies on stage differentiation of T. gondii in the murine system.

Full Text

The Full Text of this article is available as a PDF (1.8 MB).

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Abrams J. S., Pearce M. K. Development of rat anti-mouse interleukin 3 monoclonal antibodies which neutralize bioactivity in vitro. J Immunol. 1988 Jan 1;140(1):131–137. [PubMed] [Google Scholar]
  2. Bohne W., Heesemann J., Gross U. Induction of bradyzoite-specific Toxoplasma gondii antigens in gamma interferon-treated mouse macrophages. Infect Immun. 1993 Mar;61(3):1141–1145. doi: 10.1128/iai.61.3.1141-1145.1993. [DOI] [PMC free article] [PubMed] [Google Scholar]
  3. Bohne W., Heesemann J., Gross U. Reduced replication of Toxoplasma gondii is necessary for induction of bradyzoite-specific antigens: a possible role for nitric oxide in triggering stage conversion. Infect Immun. 1994 May;62(5):1761–1767. doi: 10.1128/iai.62.5.1761-1767.1994. [DOI] [PMC free article] [PubMed] [Google Scholar]
  4. Conley F. K., Jenkins K. A., Remington J. S. Toxoplasma gondii infection of the central nervous system. Use of the peroxidase-antiperoxidase method to demonstrate toxoplasma in formalin fixed, paraffin embedded tissue sections. Hum Pathol. 1981 Aug;12(8):690–698. doi: 10.1016/s0046-8177(81)80170-0. [DOI] [PubMed] [Google Scholar]
  5. Cornelissen A. W., Overdulve J. P., Hoenderboom J. M. Separation of Isospora (Toxoplasma) gondii cysts and cystozoites from mouse brain tissue by continuous density-gradient centrifugation. Parasitology. 1981 Aug;83(Pt 1):103–108. doi: 10.1017/s0031182000050071. [DOI] [PubMed] [Google Scholar]
  6. Darcy F., Charif H., Caron H., Deslée D., Pierce R. J., Cesbron-Delauw M. F., Decoster A., Capron A. Identification and biochemical characterization of antigens of tachyzoites and bradyzoites of Toxoplasma gondii with cross-reactive epitopes. Parasitol Res. 1990;76(6):473–478. doi: 10.1007/BF00931052. [DOI] [PubMed] [Google Scholar]
  7. Gazzinelli R. T., Eltoum I., Wynn T. A., Sher A. Acute cerebral toxoplasmosis is induced by in vivo neutralization of TNF-alpha and correlates with the down-regulated expression of inducible nitric oxide synthase and other markers of macrophage activation. J Immunol. 1993 Oct 1;151(7):3672–3681. [PubMed] [Google Scholar]
  8. Gazzinelli R., Xu Y., Hieny S., Cheever A., Sher A. Simultaneous depletion of CD4+ and CD8+ T lymphocytes is required to reactivate chronic infection with Toxoplasma gondii. J Immunol. 1992 Jul 1;149(1):175–180. [PubMed] [Google Scholar]
  9. Godard I., Darcy F., Deslee D., Dessaint J. P., Capron A. Isotypic profiles of antibody responses to Toxoplasma gondii infection in rats and mice: kinetic study and characterization of target antigens of immunoglobulin A antibodies. Infect Immun. 1990 Aug;58(8):2446–2451. doi: 10.1128/iai.58.8.2446-2451.1990. [DOI] [PMC free article] [PubMed] [Google Scholar]
  10. Gross U., Bohne W. Toxoplasma gondii: strain- and host cell-dependent induction of stage differentiation. J Eukaryot Microbiol. 1994 Sep-Oct;41(5):10S–11S. [PubMed] [Google Scholar]
  11. Gross U., Müller W. A., Knapp S., Heesemann J. Identification of a virulence-associated antigen of Toxoplasma gondii by use of a mouse monoclonal antibody. Infect Immun. 1991 Dec;59(12):4511–4516. doi: 10.1128/iai.59.12.4511-4516.1991. [DOI] [PMC free article] [PubMed] [Google Scholar]
  12. Joiner K. A., Dubremetz J. F. Toxoplasma gondii: a protozoan for the nineties. Infect Immun. 1993 Apr;61(4):1169–1172. doi: 10.1128/iai.61.4.1169-1172.1993. [DOI] [PMC free article] [PubMed] [Google Scholar]
  13. Kasper L. H., Bradley M. S., Pfefferkorn E. R. Identification of stage-specific sporozoite antigens of Toxoplasma gondii by monoclonal antibodies. J Immunol. 1984 Jan;132(1):443–449. [PubMed] [Google Scholar]
  14. Kasper L. H., Ware P. L. Recognition and characterization of stage-specific oocyst/sporozoite antigens of Toxoplasma gondii by human antisera. J Clin Invest. 1985 May;75(5):1570–1577. doi: 10.1172/JCI111862. [DOI] [PMC free article] [PubMed] [Google Scholar]
  15. Laemmli U. K. Cleavage of structural proteins during the assembly of the head of bacteriophage T4. Nature. 1970 Aug 15;227(5259):680–685. doi: 10.1038/227680a0. [DOI] [PubMed] [Google Scholar]
  16. Luft B. J., Brooks R. G., Conley F. K., McCabe R. E., Remington J. S. Toxoplasmic encephalitis in patients with acquired immune deficiency syndrome. JAMA. 1984 Aug 17;252(7):913–917. [PubMed] [Google Scholar]
  17. McCabe R. E., Luft B. J., Remington J. S. Effect of murine interferon gamma on murine toxoplasmosis. J Infect Dis. 1984 Dec;150(6):961–962. doi: 10.1093/infdis/150.6.961. [DOI] [PubMed] [Google Scholar]
  18. Parmley S. F., Gross U., Sucharczuk A., Windeck T., Sgarlato G. D., Remington J. S. Two alleles of the gene encoding surface antigen P22 in 25 strains of Toxoplasma gondii. J Parasitol. 1994 Apr;80(2):293–301. [PubMed] [Google Scholar]
  19. Parmley S. F., Yang S., Harth G., Sibley L. D., Sucharczuk A., Remington J. S. Molecular characterization of a 65-kilodalton Toxoplasma gondii antigen expressed abundantly in the matrix of tissue cysts. Mol Biochem Parasitol. 1994 Aug;66(2):283–296. doi: 10.1016/0166-6851(94)90155-4. [DOI] [PubMed] [Google Scholar]
  20. Porter S. B., Sande M. A. Toxoplasmosis of the central nervous system in the acquired immunodeficiency syndrome. N Engl J Med. 1992 Dec 3;327(23):1643–1648. doi: 10.1056/NEJM199212033272306. [DOI] [PubMed] [Google Scholar]
  21. Soete M., Fortier B., Camus D., Dubremetz J. F. Toxoplasma gondii: kinetics of bradyzoite-tachyzoite interconversion in vitro. Exp Parasitol. 1993 May;76(3):259–264. doi: 10.1006/expr.1993.1031. [DOI] [PubMed] [Google Scholar]
  22. Soête M., Camus D., Dubremetz J. F. Experimental induction of bradyzoite-specific antigen expression and cyst formation by the RH strain of Toxoplasma gondii in vitro. Exp Parasitol. 1994 Jun;78(4):361–370. doi: 10.1006/expr.1994.1039. [DOI] [PubMed] [Google Scholar]
  23. Suzuki Y., Conley F. K., Remington J. S. Importance of endogenous IFN-gamma for prevention of toxoplasmic encephalitis in mice. J Immunol. 1989 Sep 15;143(6):2045–2050. [PubMed] [Google Scholar]
  24. Suzuki Y., Orellana M. A., Schreiber R. D., Remington J. S. Interferon-gamma: the major mediator of resistance against Toxoplasma gondii. Science. 1988 Apr 22;240(4851):516–518. doi: 10.1126/science.3128869. [DOI] [PubMed] [Google Scholar]
  25. Tomavo S., Fortier B., Soete M., Ansel C., Camus D., Dubremetz J. F. Characterization of bradyzoite-specific antigens of Toxoplasma gondii. Infect Immun. 1991 Oct;59(10):3750–3753. doi: 10.1128/iai.59.10.3750-3753.1991. [DOI] [PMC free article] [PubMed] [Google Scholar]
  26. Towbin H., Staehelin T., Gordon J. Electrophoretic transfer of proteins from polyacrylamide gels to nitrocellulose sheets: procedure and some applications. Proc Natl Acad Sci U S A. 1979 Sep;76(9):4350–4354. doi: 10.1073/pnas.76.9.4350. [DOI] [PMC free article] [PubMed] [Google Scholar]
  27. Weiss L. M., LaPlace D., Tanowitz H. B., Wittner M. Identification of Toxoplasma gondii bradyzoite-specific monoclonal antibodies. J Infect Dis. 1992 Jul;166(1):213–215. doi: 10.1093/infdis/166.1.213. [DOI] [PubMed] [Google Scholar]
  28. Woodison G., Smith J. E. Identification of the dominant cyst antigens of Toxoplasma gondii. Parasitology. 1990 Jun;100(Pt 3):389–392. doi: 10.1017/s0031182000078665. [DOI] [PubMed] [Google Scholar]

Articles from Clinical and Diagnostic Laboratory Immunology are provided here courtesy of American Society for Microbiology (ASM)

RESOURCES